Human Metabolome Technologies, Inc.

¥560.00As of Sun 8 Nov 2026, 12:00 UTC
TSE:6090Healthcare
Country Japan
PE (Fwd) •••
TSR 10Y CAGR (5.78%)
Div yield 3.21%
ROE 10.71%
Biotechnology
Beta (5Y) (0.11)
PE TTM 15.71
TSR TTM (18.36%)
Mkt cap ¥3.035B
ROIC 36.59%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥552
(1.47%)
(42.33%)
Hold 9|6|2|3|10
2Q26
3Q26
4Q26
1Q27
Earnings per share¥
7.44
8.14
8.81
9.05
24.43%
30.45%
34.44%
26.29%
Revenue¥M
170.3
180.0
184.4
194.1
16.16%
16.51%
16.58%
19.91%
Peers (US$19.27M)
Cap (US$)
PE
20.20M
—
19.32M
—
Capital
TTM
5Y
10Y
Leveragex
1.011
0.309
0.205
EBIT/Intx
0.404
2.903
2.901
Own earn%
(269.09)
(29.61)
(29.45)
Sh yield%
15.17
20.61
20.88
Owners
Insiders/Inst%
0.24
68.37
Short interest%
2.31
SBC / revenue%
0.93
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
13
Op margin range%
27–38
$1 testx
−0.9
Incr. ROIC%
9